Company intelligence / Profile preview

Pulmair Medical

San Diego, California, United Statesiris-purple-syew.squarespace.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Pulmair Medical is developing the Implantable Artificial Bronchus (IAB), a bronchoscopically implanted device for patients with COPD/emphysema. The IAB aims to reduce lung hyperinflation and improve airflow without sacrificing healthy tissue. A multicenter, prospective clinical trial of the IAB is active but not recruiting as of June 2025, enrolling 24 subjects to assess safety and effectiveness.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Pulmair Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmair Medical.

Explore the full profile